Topical Bacitracin Polymyxin B Triamcinolone for Hypergranulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hypergranulation tissue in burn care are often painful, expensive, and can exacerbate the condition due to local inflammation and irritation, necessitating the development of more effective methods.
Innovation Solution
A topical formulation comprising bacitracin, polymyxin B, and triamcinolone, applied topically with a 1:1 ratio in cream and ointment form, along with a nonstick gauze dressing, is used to treat hypergranulation tissue, with daily applications until resolution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver nitrate, hypertonic saline, or hydrocortisone cream treatments are used to address hypergranulation tissue, then the treatment can reduce hypergranulation tissue, but the treatment causes pain, increases cost, and can worsen the condition due to local inflammation and irritation
Solution Approach 1:
The patent combines multiple therapeutic agents (silver nitrate for antimicrobial activity, hypertonic saline for debridement, and hydrocortisone for anti-inflammatory effects) into a single topical formulation. This merging allows the treatment to address hypergranulation tissue effectively while reducing the harmful side effects associated with using each agent separately, as the combined formulation is applied once rather than multiple separate treatments that cause cumulative irritation and pain
Solution Approach 2:
The invention uses a composite topical formulation containing multiple active ingredients with different mechanisms of action. The formulation includes silver nitrate (antimicrobial), hypertonic saline (osmotic debridement), and hydrocortisone (anti-inflammatory), creating a multi-functional composite material that simultaneously addresses the underlying causes of hypergranulation tissue while minimizing adverse effects through synergistic action
2Ease of manufacture
If traditional wound care regimens are used to treat hypergranulation tissue, then treatment can be provided, but the methods are expensive and can lead to worsening of the condition
Solution Approach 1:
The topical formulation is designed with multi-functionality to address multiple aspects of hypergranulation tissue treatment simultaneously. It provides antimicrobial protection, osmotic debridement, and anti-inflammatory effects in a single product, eliminating the need for multiple separate expensive treatments and reducing overall treatment cost while maintaining ease of manufacture through a unified formulation approach
Data Source
AI summary
The present disclosure describes compositions for reducing hypergranulation tissue and methods of their use. The compositions comprise bacitracin, polymyxin b, and triamcinolone.